Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06822920 · ClinicalTrials.gov registry record
Post-Market Clinical Investigation Plan - Collagen Dura Membranes (DM & DMO)
A clinical trial of Repair of Dura Mater, sponsored by Collagen Matrix.
- Recruiting
- Registry status
- 110
- Enrollment target
- 1
- Study location
NCT06822920: Recruiting study of Repair of Dura Mater, sponsored by Collagen Matrix.
NCT06822920 is a study of Repair of Dura Mater that is actively recruiting participants, run by Collagen Matrix. The registered enrollment target is 110 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06822920, a study of Repair of Dura Mater, is actively recruiting participants, sponsored by Collagen Matrix.
- RECRUITING
- Registry status
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
Monitoring the Use of Collagen Dura Membrane in the Post-market phase
Conditions Studied
Study Locations (1)
Wisconsin
- Medical Collagen of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2025-01-03 |
| Est. Completion | 2025-12-30 |
What NCT06822920 shows while recruiting
NCT06822920 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Repair of Dura Mater appearing as the primary indexed condition, and to 0 interventions.
NCT06822920 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06822920 about?
NCT06822920 is a clinical study titled "Post-Market Clinical Investigation Plan - Collagen Dura Membranes (DM & DMO)". Monitoring the Use of Collagen Dura Membrane in the Post-market phase
What is the current status of trial NCT06822920?
This trial is currently recruiting. The enrollment target is 110 participants. The study started on 2025-01-03. Estimated completion is 2025-12-30.
What conditions does trial NCT06822920 study?
This clinical trial studies the following conditions: Repair of Dura Mater.
Who is sponsoring clinical trial NCT06822920?
This trial is sponsored by Collagen Matrix, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06822920 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Repair of Dura Mater
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI